174 related articles for article (PubMed ID: 11422000)
1. The effect of anastrozole on the single-dose pharmacokinetics and anticoagulant activity of warfarin in healthy volunteers.
Yates RA; Wong J; Seiberling M; Merz M; März W; Nauck M
Br J Clin Pharmacol; 2001 May; 51(5):429-35. PubMed ID: 11422000
[TBL] [Abstract][Full Text] [Related]
2. Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin in healthy males.
Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Middle MV
Arzneimittelforschung; 1996 Jan; 46(1):41-6. PubMed ID: 8821516
[TBL] [Abstract][Full Text] [Related]
3. Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies.
Vakily M; Lee RD; Wu J; Gunawardhana L; Mulford D
Clin Drug Investig; 2009; 29(1):35-50. PubMed ID: 19067473
[TBL] [Abstract][Full Text] [Related]
4. Effect of tolterodine on the anticoagulant actions and pharmacokinetics of single-dose warfarin in healthy volunteers.
Rahimy M; Hallén B; Narang P
Arzneimittelforschung; 2002; 52(12):890-5. PubMed ID: 12572529
[TBL] [Abstract][Full Text] [Related]
5. The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
Zhi J; Melia AT; Guerciolini R; Koss-Twardy SG; Passe SM; Rakhit A; Sadowski JA
J Clin Pharmacol; 1996 Jul; 36(7):659-66. PubMed ID: 8844450
[TBL] [Abstract][Full Text] [Related]
6. The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin.
Tiseo PJ; Foley K; Friedhoff LT
Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):45-50. PubMed ID: 9839766
[TBL] [Abstract][Full Text] [Related]
7. No pharmacokinetic or pharmacodynamic interaction between rivastatin and warfarin.
Schall R; Müller FO; Hundt HK; Ritter W; Duursema L; Groenewoud G; Middle MV
J Clin Pharmacol; 1995 Mar; 35(3):306-13. PubMed ID: 7608323
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole potentiates warfarin-induced prothrombin time prolongation.
Purkins L; Wood N; Kleinermans D; Nichols D
Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):24-9. PubMed ID: 14616410
[TBL] [Abstract][Full Text] [Related]
9. Effect of the catechol-O-methyltransferase inhibitor entacapone on the steady-state pharmacokinetics and pharmacodynamics of warfarin.
Dingemanse J; Meyerhoff C; Schadrack J
Br J Clin Pharmacol; 2002 May; 53(5):485-91. PubMed ID: 11994054
[TBL] [Abstract][Full Text] [Related]
10. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
[TBL] [Abstract][Full Text] [Related]
11. Lack of pharmacokinetic and pharmacodynamic interactions of roflumilast with (R, S)-warfarin in healthy adult subjects.
McCracken N; Lahu G; Bethke TD
Int J Clin Pharmacol Ther; 2011 Jun; 49(6):388-96. PubMed ID: 21612746
[TBL] [Abstract][Full Text] [Related]
12. Effect of cilostazol on the pharmacokinetics and pharmacodynamics of warfarin.
Mallikaarjun S; Bramer SL
Clin Pharmacokinet; 1999; 37 Suppl 2():79-86. PubMed ID: 10702890
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic evaluation of warfarin and rosuvastatin co-administration in healthy subjects.
Jindal D; Tandon M; Sharma S; Pillai KK
Eur J Clin Pharmacol; 2005 Oct; 61(9):621-5. PubMed ID: 16133549
[TBL] [Abstract][Full Text] [Related]
14. Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjects.
Dieterle W; Corynen S; Mann J
Br J Clin Pharmacol; 2004 Oct; 58(4):433-6. PubMed ID: 15373937
[TBL] [Abstract][Full Text] [Related]
15. Effect of the endothelin-receptor antagonist bosentan on the pharmacokinetics and pharmacodynamics of warfarin.
Weber C; Banken L; Birnboeck H; Schulz R
J Clin Pharmacol; 1999 Aug; 39(8):847-54. PubMed ID: 10434238
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of lacosamide on the pharmacokinetic and pharmacodynamic profiles of warfarin.
Stockis A; van Lier JJ; Cawello W; Kumke T; Eckhardt K
Epilepsia; 2013 Jul; 54(7):1161-6. PubMed ID: 23614393
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin.
Ragueneau-Majlessi I; Levy RH; Meyerhoff C
Epilepsy Res; 2001 Nov; 47(1-2):55-63. PubMed ID: 11673021
[TBL] [Abstract][Full Text] [Related]
18. Effects of fesoterodine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
Malhotra B; Alvey C; Gong J; Li X; Duczynski G; Gandelman K
Br J Clin Pharmacol; 2011 Aug; 72(2):257-62. PubMed ID: 21496065
[TBL] [Abstract][Full Text] [Related]
19. Lesinurad: Evaluation of Pharmacokinetic and Pharmacodynamic Interactions With Warfarin in Healthy Volunteers.
Shen Z; Lee CA; Wallach K; Valdez S; Wilson DM; Kerr B; Gillen M
Clin Pharmacol Drug Dev; 2019 Jul; 8(5):657-663. PubMed ID: 30758919
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of effects of terbinafine on single oral dose pharmacokinetics and anticoagulant actions of warfarin in healthy volunteers.
Guerret M; Francheteau P; Hubert M
Pharmacotherapy; 1997; 17(4):767-73. PubMed ID: 9250555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
